Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

AGM Statement

2 May 2014 10:00

RNS Number : 1690G
Symphony Environmental Tech. PLC
02 May 2014
 



2 May 2014

 

 

Symphony Environmental Technologies Plc

 

("Symphony" "Group" or the "Company")

 

AGM Statement

 

At the Annual General Meeting of the Company, held today, Nirj Deva DL, FRSA, MEP, Chairman of the Company, made the following statement:

 

On the 25 March 2014 we announced that in 2013 the Group saw a significant increase in revenues of 46% compared to 2012, resulting in a small EBITDA loss on recurring business of £10,000 for 2013. This compared extremely well with a £2 million EBITDA loss in 2012. The key factor is that the plastics division of the Company achieved an EBITDA profit of £220,000 in 2013 compared with a loss of £1.75 million the year before.

 

We also announced that with improved performance we continued to invest into broadening the product range for the three main sectors of our business, environmental (d2w), health and hygiene (d2p), and anti-counterfeiting (d2t). With our distribution network covering over 90 countries we are well placed to exploit the opportunities which we have created.

 

There were legislation changes that should positively impact on d2w revenues and we are also winning business on the basis of CSR values. Trials and negotiations continue to grow with our d2w d2p and d2t ranges, some of them with very large companies.

 

We also announced the commercialisation strategy for the tyre recycling division which continues to develop, with further announcements expected in the months to come.

   

We await regulatory approval for d2p in food packaging applications and we already have approvals for non food-packaging and other non food applications.

 

I am also pleased to advise that the management team and the technical team are developing exciting new formulations and IP with a focus on expanding the product range into agricultural, retail and chemical sectors.

 

In the 25th March announcement we advised of a new contract award from a major supermarket group for d2w, and that sales volumes were expected to be significant, but not verified, and with deliveries expected to commence in April. I am pleased to confirm that deliveries have started with the expectation of a full roll-out in the second half.

 

Since my last announcement, I am pleased to confirm that we have signed a product development agreement with a world leading brand, and are in negotiations with others for d2w and d2p. In addition, we have completed successful trials on new applications for the d2w and d2p technologies.

 

We look forward to a successful year ahead.

 

 

 

 

 

- Ends -

 

Contacts

Symphony Environmental Technologies Plc

 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, FD

 

 

Cantor Fitzgerald Europe

 

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Paul Jewell (Corporate Broking)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSWSWEFLSEFI
Date   Source Headline
19th Nov 20218:24 amRNSExpansion into India
12th Nov 20213:04 pmRNSSmall Cap Awards: ESG Company of the Year
25th Oct 20217:00 amRNSExclusive Distribution Agreement
5th Oct 20219:58 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSEquity subscription and grant of warrants
16th Sep 20217:00 amRNSInterim results
3rd Sep 20217:00 amRNSHealth Canada approves d2p for bread packaging
2nd Aug 20217:30 amRNSNew agreements with Meditech
27th Jul 20213:00 pmRNSHolding(s) in Company
14th Jul 20217:00 amRNSNew expanded FDA approval for d2p food packaging
13th Jul 20217:00 amRNSTrading update
28th Jun 202111:56 amRNSResult of AGM
11th Jun 202110:04 amRNSHolding(s) in Company
9th Jun 20217:00 amRNSPDMR Dealing
3rd Jun 20217:00 amRNSPosting of accounts & notice of AGM
13th May 20217:00 amRNSEU legal challenge update
23rd Apr 20217:32 amRNSd2p anti-microbial technology to protect commuters
13th Apr 20212:40 pmRNSDirector Dealing
1st Apr 20213:23 pmRNSDirector Dealing
31st Mar 20217:00 amRNSPreliminary results
30th Mar 20217:00 amRNSCompletion of 5 year Oxomar study re. d2w
12th Mar 20217:00 amRNSEU legal challenge update
9th Feb 20217:00 amRNSTrading update
21st Dec 20207:00 amRNSEU legal action
30th Nov 20207:00 amRNSPositive Coronavirus Test Results of d2p products
16th Nov 20207:00 amRNSNew d2p product launch
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Oct 20207:00 amRNSLaunch of d2p and d2w enhanced drinking straws
20th Oct 20207:00 amRNSCompletion of Eranova project financing
19th Oct 20207:00 amRNSLargest Bakery in Turkey Launches d2w Packaging
9th Oct 20207:00 amRNSExtension of Options
5th Oct 20205:52 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSUK Airport Group introduces d2w biodegradable bag
22nd Sep 20207:00 amRNSCotripal launches d2p and d2w shopping bags
16th Sep 20207:00 amRNSInvestor Meet Company presentation
15th Sep 20207:00 amRNSExercise of warrants
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:01 amRNSPositive Coronavirus test results
14th Sep 20207:00 amRNSInterim results
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:35 pmRNSPrice Monitoring Extension
12th Aug 20204:40 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20204:09 pmRNSPDMR dealing
29th Jul 20207:00 amRNSExercise of Options/PDMR dealing
28th Jul 20207:00 amRNSExercise of Options
23rd Jul 20207:00 amRNSPositive Bovine Coronavirus Test Results
22nd Jul 20207:00 amRNSExtension of warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.